The lawyers at Saiontz & Kirk, P.A. are evaluating the potential for Humira lawsuits on behalf of users of the popular arthritis and Crohn’s Disease drug who have experienced nerve damage, including multiple sclerosis, transverse myeltis, optic neuritis or other health problems.


Humira (adalimumab) is a “biologic” drug manufactured by Abbott Laboratories, which is part of a class of medications known as tumor necrosis factor blockers, or TNF blocker. Although other similar medications in the class contain warnings about the risk of nerve damage side effects, Abbott may have failed to adequately provide the same warnings for users of their medication.

Reports suggest that Humira side effects may increase the risk of central nervous system (CNS) demyelination, which can injure the myelin sheath. This may inhibit the conduction of signals in nerves and impair functioning dependent on the nerve that is affected.

Some potential health problems from Humira could include:

  • Multiple Sclerosis
  • Transverse Myelitis
  • Optic Neuritis or Vision Problems
  • Seizure Disorders

Although the potential for lawsuits over Humira are still being reviewed and evaluated, it appears that the drug maker could have provided better warnings about the risk of nerve damage from Humira. During clinical trials, at least three cases of demylination on Humira were reported, including two of which involved optic nerve damage, compared with no reports among patients taking a placebo. In addition, since the medication was approved, several reports of Humira problems have been filed with the FDA adverse event database involving neurological symptoms with Humira use, including reports of optic neuritis, which can result in permanent vision impairment.


To review a potential Humira nerve damage lawsuit for yourself a friend or family member, request a free consultation and claim evaluation. Potential lawsuits over Humira are being considered for individuals throughout the United States and there are no fees or expenses unless a recovery is obtained.